Home

Christophe Arbet-Engels, Chief Medical Officer: X4 Pharmaceuticals XFOR Sell · Filed 25/01/27

Trade details

Type
Insider sale
Amount
$5,230.8
Shares · price
11,624 sh · $0.45 a share
Held after
14,207 sh
Trade date
25/01/24
Filed
25/01/27
Days to filing
3 days

Sold 45.0% of holdings

Share of holding sold
45.0%

X4 Pharmaceuticals trades, last 26 weeks

What else happened in X4 Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/25~25/02/23

Christophe Arbet-Engels's recent trades

  • Christophe Arbet-Engels

    Planned sale10b5-1 planX4 Pharmaceuticals

    $6,044

    Filed 25/01/24